Skip to main content

Table 3 Pre-treatment genitourinary morbidity and genitourinary acute and late toxicity

From: Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

  

Pre-Tx

Acute†

Late‡

Last late§

Toxicity

Grade

n (%)

n (%)

n (%)

n (%)

Dysuria

0

36 (92)

20 (51)

35 (90)

38 (97)

 

1

3 (8)

13 (33)

4 (10)

1 (3)

 

2

0

5 (13)

0

0

 

3

0

1 (3)

0

0

Incontinence

0

34 (87)

33 (84)

34 (87)

37 (94)

 

1

4 (10)

5 (13)

4 (10)

1 (3)

 

2

1 (3)

1 (3)

1 (3)

1 (3)

Retention

0

20 (51)

16 (41)

23 (59)

34 (86)

 

1

13 (33)

9 (23)

11 (28)

3 (8)

 

2

5 (13)

12 (31)

4 (10)

1 (3)

 

3

1 (3)

2 (5)

1 (3)

1 (3)

Frequency/urgency

0

23 (59)

6 (15)

17 (44)

23 (59)

 

1

13 (33)

16 (41)

15 (38)

14 (36)

 

2

2 (5)

15 (39)

7 (18)

2 (5)

 

3

1 (3)

2 (5)

0

0

Hematuria

0

39 (100)

39 (100)

36 (92)

37 (95)

 

1

0

0

1 (3)

2 (5)

 

2

0

0

2 (5)

0

Highest GU*

0

15 (39)

1 (3)

11 (28)

19 (49)

 

1

14 (36)

13 (33)

16 (41)

13 (33)

 

2

8 (20)

22 (56)

11 (28)

6 (15)

 

3

2 (5)

3 (8)

1 (3)

1 (3)

  1. Abbreviations: Pre-Tx = pre-treatment; * The highest toxicity in a patient was counted as a single event; † During therapy and until 3 months after completion; ‡ maximal late toxicity > 3 months after completion of therapy; § Incidence of late toxicity at last follow-up visit